tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
BCRX is currently covered by 9 analysts with an average price target of $14.4. This is a potential upside of $6.53 (82.97%) from yesterday's end of day stock price of $7.87.
BioCryst Pharmaceuticals's activity chart (see below) currently has 131 price targets and 120 ratings on display. The stock rating distribution of BCRX is 86.67% BUY and 13.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 54.25% with an average time for these price targets to be met of 358.5 days.
Highest price target for BCRX is $30, Lowest price target is $8, average price target is $14.4.
Most recent stock forecast was given by LIISA BAYKO from EVERCORE on 13-Jan-2025. First documented stock forecast 18-Feb-2014.
Currently out of the existing stock ratings of BCRX, 26 are a BUY (86.67%), 4 are a HOLD (13.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$4.36 (57.07%)
$10
17 days ago
(13-Jan-2025)
7/12 (58.33%)
$4.43 (58.52%)
759
Buy
$15
$7.36 (96.34%)
$14
17 days ago
(13-Jan-2025)
3/11 (27.27%)
$7.43 (98.15%)
348
Hold
$8
$0.36 (4.71%)
$7
2 months 25 days ago
(05-Nov-2024)
7/11 (63.64%)
$0.77 (10.65%)
37
Buy
$10
$2.36 (30.89%)
$10
2 months 25 days ago
(05-Nov-2024)
16/22 (72.73%)
$2.77 (38.31%)
510
Buy
$16
$8.36 (109.42%)
$15
5 months 24 days ago
(06-Aug-2024)
4/11 (36.36%)
$8.13 (103.30%)
149
What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?
Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?
